Cytogenetics in adult acute lymphocytic leukemia

Hematology/Oncology Clinics of North America

Volumn 14, Issue 6, 2000, Pages 1237-1249

  Wetzler, Meir ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME ABERRATION; CYTOGENETICS; HUMAN; KARYOTYPE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVIEW; TRISOMY;

EID: 0033634747     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8588(05)70184-2     Document Type: Review

References (26)

1. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults. M.R.C. Adult Leukaemia Working Party
2. Acute lymphoblastic leukemia and chromosome 21
3. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia
4. Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia
5. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia Group B study 8364
6. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: Long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose ara-c and melphalan)
7. Activity of an Abl specific tyrosine kinase inhibitor in patients with BCR-ABL positive acute leukemia, including chronic myelogenous leukemia in blast crisis
8. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
9. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
10. Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3
11. Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemia
12. Hematologic malignancies with t(4;11)(q21;q23) - A cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants
13. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia
14. Acute leukemias with the t(4;11)(q21;q23)
15. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation
16. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia
17. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia
18. Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): The implication of additional chromosomal aberrations
19. Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance
20. On behalf of the MRC Adult Leukaemia Working Party: Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA
21. Ph positive acute lymphoblastic leukemia in adults: Molecular and clinical studies
22. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia
23. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique
24. The importance of cytogenetic studies in adult acute lymphocytic leukemia
25. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762)
26. Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience